STAAR Surgical Co Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price
STAAR Surgical Co (STAA) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price of $40.03 per share for the 6-month period ending 2026-07-03, per its 10-Q filed 2026-08-12.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice · last filed 2026-08-12
- STAAR Surgical Co share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period, weighted average exercise price for the quarter ending 2026-04-03 was $34.50, a 19.90% decline year-over-year.
- STAAR Surgical Co share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period, weighted average exercise price for the quarter ending 2025-03-28 was $43.07, a 43.37% decline year-over-year.
- STAAR Surgical Co share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period, weighted average exercise price for the quarter ending 2024-03-29 was $76.05.
- STAAR Surgical Co share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period, weighted average exercise price for fiscal 2026 was $50.48, a 28.33% decline from fiscal 2024.
- STAAR Surgical Co share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period, weighted average exercise price for fiscal 2024 was $70.43, a 2.59% decline from fiscal 2023.
- STAAR Surgical Co share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period, weighted average exercise price for fiscal 2023 was $72.30, a 12.14% decline from fiscal 2022.
- STAAR Surgical Co share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period, weighted average exercise price for fiscal 2022 was $82.29, a 143.68% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price 12 month |
|---|---|---|---|---|
| 2026-07-03 | $40.03 10-Q · filed 2026-08-12 | |||
| 2026-04-03 | $34.50 10-Q · filed 2026-05-13 | |||
| 2026-01-02 | $50.48 10-K · filed 2026-03-03 | |||
| 2025-09-26 | $50.16 10-Q · filed 2025-11-05 | |||
| 2025-06-27 | $47.71 10-Q · filed 2025-08-06 | |||
| 2025-03-28 | $43.07 10-Q · filed 2025-05-07 | |||
| 2024-12-27 | $70.43 10-K · filed 2025-02-21 | |||
| 2024-09-27 | $70.90 10-Q · filed 2024-10-30 | |||
| 2024-06-28 | $69.44 10-Q · filed 2024-08-07 | |||
| 2024-03-29 | $76.05 10-Q · filed 2024-05-07 | |||
| 2023-12-29 | $72.30 10-K · filed 2024-02-27 | |||
| 2023-09-29 | $72.49 10-Q · filed 2023-11-06 | |||
| 2022-12-30 | $82.29 10-K · filed 2023-02-23 | |||
| 2021-12-31 | $33.77 10-K · filed 2022-02-23 | |||
| 2021-01-01 | $32.35 10-K · filed 2021-02-24 | |||
| 2020-01-03 | $25.87 10-K · filed 2020-02-26 | |||
| 2018-12-28 | $11.27 10-K · filed 2019-02-21 | |||
| 2017-12-29 | $11.62 10-K · filed 2018-02-28 | |||
| 2016-12-30 | $9.23 10-K · filed 2017-03-02 | |||
| 2016-01-01 | $10.57 10-K · filed 2016-03-11 | |||
| 2015-01-02 | $11.92 10-K · filed 2015-03-13 | |||
| 2014-01-03 | $8.53 10-K · filed 2014-03-12 | |||
| 2012-12-28 | $6.87 10-K · filed 2013-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| National Vision Holdings, Inc. (EYE) | United States | $1.297B | |
| RxSight, Inc. (RXST) | United States | $0.197B | |
| Innovative Eyewear Inc (LUCY) | United States | $0.008B | |
| Warby Parker Inc. (WRBY) | United States | $2.970B | |
| Bausch & Lomb Corp (BLCO) | Canada | $6.008B | -34.58 |
| COOPER COMPANIES, INC. (COO) | United States | $10.533B | 24.09 |